Diagnostics

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate

Radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences and the largest public hospital in…

7 months ago

Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path

Disruptive Biotech Firm Appoints Public Markets Veteran Nelson Grist as its Chief Executive Officer and Future Member of its Board…

7 months ago

ProPhase Labs Unveils Project ZenQ-AI

Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City,…

7 months ago

GeneType Clinicians’ Adoption Growing – Sales up 5-Fold Year on Year

MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader…

7 months ago

Multicancer Screening Market Projected to Reach $2.72 billion by 2030 – Exclusive Report by 360iResearch

PUNE, India, April 15, 2024 /PRNewswire/ -- The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms,…

7 months ago

Q4HE Initiative Recognized for Efforts To Reduce Health Disparities

NORTHAMPTON, MA / ACCESSWIRE / April 15, 2024 / Quest for Health Equity (Q4HE) was recently honored by the Y…

7 months ago

Nexstim Plc Resolved on a New Stock Option Plan 2024H

Company Announcement, Helsinki, 12 April 2024 at 9 PM (EEST) Nexstim Plc Resolved on a New Stock Option Plan 2024H…

7 months ago

Oncocyte Reports Full Year 2023 Financial Results

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ETIRVINE, Calif., April 12, 2024 (GLOBE…

7 months ago

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a precision diagnostics company,…

7 months ago

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring…

7 months ago